Literature DB >> 3530879

High-level expression of a gene encoding the human complement factor C5a in Escherichia coli.

W Mandecki, B S Powell, K W Mollison, G W Carter, J L Fox.   

Abstract

The synthetic C5a gene was initially found to be expressed poorly in Escherichia coli. We undertook studies to determine the reasons for poor expression and to increase expression. The work was focused on the role of the mRNA structure in C5a expression and stability of its product in E. coli. We present data on the effects of varying the sequence at the 5' end of mRNA as well as different ribosome-binding sites on expression. Evaluation of the stability of C5a showed rapid degradation of C5a in wild-type E. coli (half-life 3-5 min). Screening of several protease-deficient strains of E. coli showed that C5a was much more stable in an htpR strain carrying a mutation in the sigma subunit of RNA polymerase that is specific for heat shock promoters. The mutation is associated with a proteolytic deficiency. The half-life of C5a was increased to 20 min. By manipulating the expression vector, the regulatory region for the C5a gene, the host strain, growth conditions and methods for recovering the protein, C5a levels were increased 300-fold over previously reported amounts to about 3% of total cellular protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530879     DOI: 10.1016/0378-1119(86)90016-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors:  K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus.

Authors:  J F Bohnsack; K W Mollison; A M Buko; J C Ashworth; H R Hill
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

3.  Lysis of Escherichia coli by the bacteriophage phi X174 E protein: inhibition of lysis by heat shock proteins.

Authors:  K D Young; R J Anderson; R J Hafner
Journal:  J Bacteriol       Date:  1989-08       Impact factor: 3.490

4.  A cryptic RNA-binding domain in the Pol region of the L-A double-stranded RNA virus Gag-Pol fusion protein.

Authors:  J C Ribas; T Fujimura; R B Wickner
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  High-level C5a gene expression and recovery of recombinant human C5a from Escherichia coli.

Authors:  K W Mollison; T A Fey; R A Krause; W Mandecki; J L Fox; G W Carter
Journal:  Agents Actions       Date:  1987-08

6.  Oligonucleotide-directed double-strand break repair in plasmids of Escherichia coli: a method for site-specific mutagenesis.

Authors:  W Mandecki
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.

Authors:  D F Carney; T E Hugli
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

8.  Expression and subcellular targeting of human complement factor C5a in Nicotiana species.

Authors:  Henrik Nausch; Heike Mikschofsky; Heike Mischofsky; Roswitha Koslowski; Udo Meyer; Inge Broer; Jana Huckauf
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.